TY - JOUR
T1 - Relationship between decrements in glucose level and metabolic response to hypoglycemia in absence of counterregulatory hormones in the conscious dog
AU - Connolly, C. C.
AU - Adkins-Marshall, B. A.
AU - Neal, D. W.
AU - Pugh, W.
AU - Jaspan, J. B.
AU - Cherrington, A. D.
PY - 1992/10
Y1 - 1992/10
N2 - To determine the relationship between decreases in glucose and metabolic regulation in the absence of counterregulatory hormones, we infused overnight-fasted, conscious, adrenalectomized dogs (lacking cortisol and EPI) with somatostatin (to eliminate glucagon and growth hormone) and intraportal insulin (30 pmol · kg-1 · min-1), creating arterial insulin levels of ∼2000 pM. Glucose was infused during one 120-min period, two 90-min periods, and one 45-min period to establish levels of 5.9 ± 0.1, 3.4 ± 0.1, 2.5 ± 0.1, and 1.7 ± 0.1 mM, respectively. NE levels were 1.24 ± 0.23, 1.85 ± 0.27, 2.04 ± 0.26, and 2.50 ± 0.20 nM, respectively. During the euglycemic control period, the liver took up glucose (7.5 ± 1.9 μmol · kg-1 · min-1), but hypoglycemia triggered successively greater rates of net hepatic glucose output (3.0 ± 0.7, 4.6 ± 0.9, and 6.9 ± 1.4 μmol · kg-1 · min-1). Total gluconeogenic precursor uptake by the liver increased with hypoglycemia. Intrahepatic gluconeogenic efficiency rose progressively (by 106 ± 42, 199 ± 56, and 268 ± 55%). Both glycerol and NEFA levels rose, indicating lipolysis was enhanced. Net hepatic NEFA uptake and ketone production increased proportionally, but the ketone level rose only with severe hypoglycemia. In conclusion, despite marked hyperinsulinemia and the absence of glucagon, EPI, and cortisol, we observed that lipolysis and glucose and ketone production increase in response to decreases in glucose. This suggests that neural and/or autoregulatory mechanisms can play a role in combating hypoglycemia.
AB - To determine the relationship between decreases in glucose and metabolic regulation in the absence of counterregulatory hormones, we infused overnight-fasted, conscious, adrenalectomized dogs (lacking cortisol and EPI) with somatostatin (to eliminate glucagon and growth hormone) and intraportal insulin (30 pmol · kg-1 · min-1), creating arterial insulin levels of ∼2000 pM. Glucose was infused during one 120-min period, two 90-min periods, and one 45-min period to establish levels of 5.9 ± 0.1, 3.4 ± 0.1, 2.5 ± 0.1, and 1.7 ± 0.1 mM, respectively. NE levels were 1.24 ± 0.23, 1.85 ± 0.27, 2.04 ± 0.26, and 2.50 ± 0.20 nM, respectively. During the euglycemic control period, the liver took up glucose (7.5 ± 1.9 μmol · kg-1 · min-1), but hypoglycemia triggered successively greater rates of net hepatic glucose output (3.0 ± 0.7, 4.6 ± 0.9, and 6.9 ± 1.4 μmol · kg-1 · min-1). Total gluconeogenic precursor uptake by the liver increased with hypoglycemia. Intrahepatic gluconeogenic efficiency rose progressively (by 106 ± 42, 199 ± 56, and 268 ± 55%). Both glycerol and NEFA levels rose, indicating lipolysis was enhanced. Net hepatic NEFA uptake and ketone production increased proportionally, but the ketone level rose only with severe hypoglycemia. In conclusion, despite marked hyperinsulinemia and the absence of glucagon, EPI, and cortisol, we observed that lipolysis and glucose and ketone production increase in response to decreases in glucose. This suggests that neural and/or autoregulatory mechanisms can play a role in combating hypoglycemia.
UR - https://www.scopus.com/pages/publications/0026731956
M3 - Article
C2 - 1397705
AN - SCOPUS:0026731956
SN - 0012-1797
VL - 41
SP - 1308
EP - 1319
JO - Diabetes
JF - Diabetes
IS - 10
ER -